Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro (Q34793691)
scientific article
Language:
(P31) (Q13442814)
(P304) 133-138
(P407) (Q1860)
(P433) 1
(P478) 96
(P577) Friday, January 1, 1999
(P921) (Q27109835)
(P1104) 6
(P1433) (Q1146531)
(P1476) "Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro" (language: en)
(P2093) Fisher JE
Rogers MJ
Halasy JM
Luckman SP
Hughes DE
Masarachia PJ
Wesolowski G
Russell RG
Rodan GA
Reszka AA
(P2860) (Q42543174)
(Q41658828)
(Q41092717)
(Q34438194)
(Q28307077)
(Q39766013)
(Q37685549)
(Q42557625)
(Q40928568)
(Q33898760)
(Q34244296)
(Q41714893)
(Q34216753)
(Q41595156)
(Q35378433)
(Q69363944)
(Q59061245)
(Q72577779)
(Q72582036)
(Q71975600)
(Q71207806)
(Q71692078)
(Q71722781)
(Q57970668)
other details